If 400m+ people live with COPD, why aren’t we talking about it?

Experts Kaivan Khavandi and Dave Singh discuss diseases that affect a fundamental aspect of life – breathing. Developed and funded by GSK. Show note: In the second Behind the Science episode, Dr. Kat Arney speaks with Professor Dave Singh, a specialist in respiratory pharmacology at the University of Manchester, and Dr. Kaivan Khavandi, Senior Vice President and Global Head of Respiratory, Immunology and Inflammation Research at GSK, to take a closer look at a disease that affects a fundamental part of life – breathing. Together they explore COPD, unpacking how it affects everyday life and why severe flare-ups can have such serious consequences. If you want to hear more episodes make sure to subscribe to the podcast. For more on how today’s discoveries are shaping tomorrow’s health, you can visit Behind the Science at GSK.com: https://www.gsk.com/en-gb/behind-the-...